D.E. Shaw & Co
KOD icon

D.E. Shaw & Co’s Kodiak Sciences KOD Stock Holding History

D.E. Shaw & Co’s Portfolio KOD Stock Details KOD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.77M Sell
229,955
-90,692
-28% -$2.34M 0.01% 1748
2025
Q4 		$8.97M Sell
320,647
-137,209
-30% -$2.81M ﹤0.01% 1858
2025
Q3 		$7.5M Sell
457,856
-143,773
-24% -$1.24M ﹤0.01% 1880
2025
Q2 		$2.24M Sell
601,629
-166,796
-22% -$591K ﹤0.01% 2653
2025
Q1 		$2.16M Sell
768,425
-83,651
-10% -$455K ﹤0.01% 2552
2024
Q4 		$8.48M Sell
852,076
-66,684
-7% -$383K 0.01% 1607
2024
Q3 		$2.4M Sell
918,760
-26,392
-3% -$70.2K ﹤0.01% 2578
2024
Q2 		$2.22M Sell
945,152
-99,498
-10% -$337K ﹤0.01% 2566
2024
Q1 		$5.49M Sell
1,044,650
-164,323
-14% -$805K ﹤0.01% 1818
2023
Q4 		$3.68M Buy
1,208,973
+212,840
+21% +$473K ﹤0.01% 2166
2023
Q3 		$1.79M Buy
996,133
+7,436
+0.8% +$26.2K ﹤0.01% 2663
2023
Q2 		$6.82M Sell
988,697
-93,003
-9% -$569K 0.01% 1641
2023
Q1 		$6.71M Sell
1,081,700
-83,552
-7% -$585K 0.01% 1697
2022
Q4 		$8.34M Buy
1,165,252
+180,183
+18% +$1.29M 0.01% 1606
2022
Q3 		$7.62M Buy
985,069
+1,502
+0.2% +$14.6K 0.01% 1609
2022
Q2 		$7.51M Sell
983,567
-14,257
-1% -$100K 0.01% 1676
2022
Q1 		$7.7M Buy
997,824
+994,647
+31,308% +$38.8M 0.01% 1855
2021
Q4 		$269K Sell
3,177
-7,314
-70% -$744K ﹤0.01% 4730
2021
Q3 		$1.01M Buy
+10,491
New +$969K ﹤0.01% 3595
2021
Q2 		– Sell
-11,391
Closed -$1.29M – 4884
2021
Q1 		$1.29M Buy
+11,391
New +$1.56M ﹤0.01% 2909
2020
Q4 		– Sell
-17,055
Closed -$1.01M – 4033
2020
Q3 		$1.01M Sell
17,055
-2,090
-11% -$105K ﹤0.01% 2849
2020
Q2 		$1.04M Sell
19,145
-4,387
-19% -$247K ﹤0.01% 2902
2020
Q1 		$1.12M Sell
23,532
-94,309
-80% -$5.66M ﹤0.01% 2646
2019
Q4 		$8.48M Buy
+117,841
New +$4.29M 0.01% 1323

Other funds holding KOD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

D.E. Shaw & Co's KOD Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Kodiak Sciences (KOD) stake by 28% in Q1 2026, selling an estimated $2.34M and leaving 229,955 shares worth $8.77M. The position accounts for 0.01% of the portfolio, ranked #1748.

D.E. Shaw & Co first reported a position in KOD in Q4 2019 and has held it in 24 quarters since. The position peaked at $8.97M in Q4 2025. 188 funds tracked by Wall St. Rank hold KOD as of Q1 2026.

  • D.E. Shaw & Co held 229,955 shares of Kodiak Sciences worth $8.77M as of Q1 2026.
  • D.E. Shaw & Co sold 90,692 Kodiak Sciences shares in Q1 2026, an estimated $2.34M.
  • Kodiak Sciences made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1748 holding.
  • D.E. Shaw & Co first reported a position in Kodiak Sciences in Q4 2019 and has held it in 24 quarters since.
  • D.E. Shaw & Co's Kodiak Sciences position peaked at $8.97M in Q4 2025.
  • 188 funds tracked by Wall St. Rank held Kodiak Sciences as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.